DK1945631T3 - 4- (3-aminopyrazole) pyrimidinderivater til anvendelse som tyrosinkinaseinhibitorer til behandling af cancer - Google Patents
4- (3-aminopyrazole) pyrimidinderivater til anvendelse som tyrosinkinaseinhibitorer til behandling af cancerInfo
- Publication number
- DK1945631T3 DK1945631T3 DK06794902.4T DK06794902T DK1945631T3 DK 1945631 T3 DK1945631 T3 DK 1945631T3 DK 06794902 T DK06794902 T DK 06794902T DK 1945631 T3 DK1945631 T3 DK 1945631T3
- Authority
- DK
- Denmark
- Prior art keywords
- aminopyrazole
- cancer treatment
- pyrimidine derivatives
- derivatives used
- tyrosinkinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73129905P | 2005-10-28 | 2005-10-28 | |
US80306106P | 2006-05-24 | 2006-05-24 | |
PCT/GB2006/003978 WO2007049041A1 (en) | 2005-10-28 | 2006-10-26 | 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1945631T3 true DK1945631T3 (da) | 2012-10-22 |
Family
ID=37575154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06794902.4T DK1945631T3 (da) | 2005-10-28 | 2006-10-26 | 4- (3-aminopyrazole) pyrimidinderivater til anvendelse som tyrosinkinaseinhibitorer til behandling af cancer |
Country Status (22)
Country | Link |
---|---|
US (3) | US20080287475A1 (da) |
EP (2) | EP2388259A1 (da) |
JP (1) | JP2009513615A (da) |
KR (1) | KR20080063846A (da) |
AR (1) | AR056210A1 (da) |
AU (1) | AU2006307657B2 (da) |
BR (1) | BRPI0618011A2 (da) |
CA (1) | CA2626375A1 (da) |
DK (1) | DK1945631T3 (da) |
EC (1) | ECSP088450A (da) |
ES (1) | ES2391783T3 (da) |
HR (1) | HRP20120824T1 (da) |
IL (1) | IL190935A0 (da) |
MX (1) | MX2008005398A (da) |
NO (1) | NO20081893L (da) |
NZ (1) | NZ567584A (da) |
PL (1) | PL1945631T3 (da) |
PT (1) | PT1945631E (da) |
RU (1) | RU2463302C2 (da) |
TW (1) | TW200800963A (da) |
UY (1) | UY29886A1 (da) |
WO (1) | WO2007049041A1 (da) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4377583B2 (ja) * | 2000-12-05 | 2009-12-02 | バーテックス ファーマシューティカルズ インコーポレイテッド | C−junn末端キナーゼ(jnk)および他のタンパク質キナーゼのインヒビター |
PL1846394T3 (pl) * | 2005-02-04 | 2012-04-30 | Astrazeneca Ab | Pochodne pirazoliloaminopirydyny użyteczne jako inhibitory kinazy |
SI1853588T1 (sl) | 2005-02-16 | 2008-10-31 | Astrazeneca Ab | Kemične spojine |
EP1899323A2 (en) * | 2005-05-16 | 2008-03-19 | AstraZeneca AB | Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors |
BRPI0618011A2 (pt) * | 2005-10-28 | 2011-08-16 | Astrazeneca Ab | composto ou um sal farmaceuticamente aceitável do mesmo, processo para a preparação do mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito anti-proliferativo e um efeito pró-apoptósico em um animal de sangue quente, para tratar doença e para produzir um efeito inibidor de jak em um animal de sangue quente |
EP2348023B9 (en) | 2005-12-13 | 2017-03-08 | Incyte Holdings Corporation | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
KR101435231B1 (ko) | 2006-08-24 | 2014-10-02 | 아스트라제네카 아베 | 증식성 질환의 치료에 유용한 모르폴리노 피리미딘 유도체 |
WO2008061370A1 (en) * | 2006-11-24 | 2008-05-29 | Mcmaster University | Diagnostic method to detect endometriosis |
CN101679429A (zh) * | 2007-04-18 | 2010-03-24 | 阿斯利康(瑞典)有限公司 | 5-氨基吡唑-3-基-3h-咪唑并[4,5-b]吡啶衍生物及其治疗癌的用途 |
ES2369596T3 (es) * | 2007-05-04 | 2011-12-02 | Astrazeneca Ab | Derivados de amino-tiazolil-pirimidina y su uso para el tratamiento del cáncer. |
UA99459C2 (en) * | 2007-05-04 | 2012-08-27 | Астразенека Аб | 9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer |
CN101932582B (zh) | 2007-06-13 | 2013-09-25 | 因塞特公司 | 詹纳斯激酶抑制剂(R)-3-(4-(7H-吡咯并[2,3-d]嘧啶-4-基)-1H-吡唑-1-基)-3-环戊基丙腈的盐 |
EA018708B1 (ru) | 2007-07-09 | 2013-10-30 | Астразенека Аб | ПРОИЗВОДНЫЕ МОРФОЛИНОПИРИМИДИНА, ИСПОЛЬЗУЕМЫЕ ПРИ ЗАБОЛЕВАНИЯХ, СВЯЗАННЫХ С mTOR КИНАЗОЙ И/ИЛИ PI3K |
WO2009007753A2 (en) * | 2007-07-11 | 2009-01-15 | Astrazeneca Ab | 4- (3-aminopyrazole) -pyrimidine derivativee and their use as tyrosine kinase inhibitors for the treatment of cancer |
WO2009013545A2 (en) * | 2007-07-26 | 2009-01-29 | Astrazeneca Ab | Chemical compounds |
TW200906818A (en) * | 2007-07-31 | 2009-02-16 | Astrazeneca Ab | Chemical compounds |
EP2220068B1 (en) | 2007-11-16 | 2016-01-27 | Incyte Holdings Corporation | 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
WO2009095712A2 (en) * | 2008-01-29 | 2009-08-06 | Astrazeneca Ab | Chemical compounds |
UY31885A (es) * | 2008-06-11 | 2010-01-29 | Astrazeneca Ab | Derivados de las 1, 3, 5-triazina-2, 4-diaminas-6-sustituidas-n-sustituidas y sales farmacéuticamente aceptables de los mismos, composiciones y aplicaciones. |
TW201011017A (en) * | 2008-08-19 | 2010-03-16 | Astrazeneca Ab | Chemical compounds 495-1 |
CA2737217A1 (en) * | 2008-09-30 | 2010-04-08 | Astrazeneca Ab | Heterocyclic jak kinase inhibitors |
CN102458581B (zh) | 2009-05-22 | 2016-03-30 | 因塞特控股公司 | 作为JANUS激酶抑制剂的吡唑-4-基-吡咯并[2,3-d]嘧啶和吡咯-3-基-吡咯并[2,3-d]嘧啶的N-(杂)芳基-吡咯烷衍生物 |
SG176111A1 (en) | 2009-05-22 | 2011-12-29 | Incyte Corp | 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors |
US8933227B2 (en) | 2009-08-14 | 2015-01-13 | Boehringer Ingelheim International Gmbh | Selective synthesis of functionalized pyrimidines |
JP5539518B2 (ja) | 2009-08-14 | 2014-07-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 2−アミノ−5−トリフルオロメチルピリミジン誘導体の位置選択的調製 |
US9249145B2 (en) | 2009-09-01 | 2016-02-02 | Incyte Holdings Corporation | Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors |
ME02386B (me) | 2010-03-10 | 2016-09-20 | Incyte Holdings Corp | Derivati piperidin-4-il azetidina kao inhibitori jak1 |
KR102303885B1 (ko) | 2010-05-21 | 2021-09-24 | 인사이트 홀딩스 코포레이션 | Jak 저해제에 대한 국소 제형 |
SA111320519B1 (ar) | 2010-06-11 | 2014-07-02 | Astrazeneca Ab | مركبات بيريميدينيل للاستخدام كمثبطات atr |
BR112013008420A2 (pt) | 2010-10-07 | 2016-06-28 | Takeda Pharmaceutical | composto, medicamento, e, uso do composito |
JP2012102088A (ja) * | 2010-10-14 | 2012-05-31 | Sumitomo Chemical Co Ltd | ヘテロ芳香環化合物およびその有害生物防除用途 |
EP2640723A1 (en) | 2010-11-19 | 2013-09-25 | Incyte Corporation | Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors |
US9034884B2 (en) | 2010-11-19 | 2015-05-19 | Incyte Corporation | Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors |
US8691807B2 (en) | 2011-06-20 | 2014-04-08 | Incyte Corporation | Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors |
EP2554544A1 (en) * | 2011-08-01 | 2013-02-06 | Almirall, S.A. | Pyridin-2(1h)-one derivatives as jak inhibitors |
TW201313721A (zh) | 2011-08-18 | 2013-04-01 | Incyte Corp | 作為jak抑制劑之環己基氮雜環丁烷衍生物 |
MX2014002208A (es) * | 2011-08-25 | 2014-05-28 | Hoffmann La Roche | Inhibidores de serina/treonina quinasa. |
JP2014525418A (ja) * | 2011-09-05 | 2014-09-29 | 浙江海正薬業股▲ふん▼有限公司 | タンパク質キナーゼ阻害活性を有する4−置換−(3−置換−1h−ピラゾール−5−アミノ)−ピリミジン誘導体及びその使用 |
UA111854C2 (uk) | 2011-09-07 | 2016-06-24 | Інсайт Холдінгс Корпорейшн | Способи і проміжні сполуки для отримання інгібіторів jak |
BR112014015549A8 (pt) | 2011-12-22 | 2017-07-04 | Hoffmann La Roche | composto, método de inibição da atividade pak1, método para o tratamento, processo, composição, utilização de um composto e invenção |
TW201406761A (zh) | 2012-05-18 | 2014-02-16 | Incyte Corp | 做爲jak抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物 |
EA201590930A1 (ru) | 2012-11-15 | 2015-08-31 | Инсайт Корпорейшн | Лекарственные формы руксолитиниба с замедленным высвобождением |
JP6397831B2 (ja) | 2013-03-06 | 2018-09-26 | インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation | Jak阻害剤の製造方法及びその中間体 |
MY195091A (en) | 2013-08-07 | 2023-01-10 | Incyte Corp | Sustained Release Dosage Forms for a JAK1 Inhibitor |
WO2015184305A1 (en) | 2014-05-30 | 2015-12-03 | Incyte Corporation | TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1 |
HRP20220738T1 (hr) | 2014-08-11 | 2022-08-19 | Acerta Pharma B.V. | Terapijske kombinacije inhibitora btk, inhibitora pd-1 i/ili inhibitora pd-l1 |
EP3179991B1 (en) | 2014-08-11 | 2021-10-06 | Acerta Pharma B.V. | Therapeutic combinations of a btk inhibitor and a bcl-2 inhibitor |
CN111646980B (zh) | 2015-09-25 | 2021-08-27 | 迪哲(江苏)医药股份有限公司 | 用于抑制jak的化合物和方法 |
WO2019113487A1 (en) | 2017-12-08 | 2019-06-13 | Incyte Corporation | Low dose combination therapy for treatment of myeloproliferative neoplasms |
CR20200379A (es) | 2018-01-30 | 2021-03-05 | Incyte Corp | Procesos e intermedio para elaborar un inhibidor de jak campo técnico |
CA3095487A1 (en) | 2018-03-30 | 2019-10-03 | Incyte Corporation | Treatment of hidradenitis suppurativa using jak inhibitors |
TWI759829B (zh) * | 2019-08-23 | 2022-04-01 | 財團法人生物技術開發中心 | 作為第iii型受體酪胺酸激酶抑制劑之雜環吡唑衍生物 |
US11833155B2 (en) | 2020-06-03 | 2023-12-05 | Incyte Corporation | Combination therapy for treatment of myeloproliferative neoplasms |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2426180A1 (de) | 1974-05-29 | 1975-12-18 | Bayer Ag | Verfahren zum faerben von polyurethankunststoffen |
US4485284A (en) | 1982-01-11 | 1984-11-27 | Advanced Moisture Technology, Inc. | Apparatus and process for microwave moisture analysis |
HU206337B (en) | 1988-12-29 | 1992-10-28 | Mitsui Petrochemical Ind | Process for producing pyrimidine derivatives and pharmaceutical compositions |
US5521184A (en) | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
CA2104053C (en) | 1992-08-31 | 1999-04-13 | Miguel A. Cacho | Automated fluid bed process |
US5543520A (en) | 1993-10-01 | 1996-08-06 | Ciba-Geigy Corporation | Pyrimidine derivatives |
US5935966A (en) | 1995-09-01 | 1999-08-10 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions |
WO1997009325A1 (en) | 1995-09-01 | 1997-03-13 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions |
GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
HUP9901155A3 (en) | 1996-02-13 | 2003-04-28 | Astrazeneca Ab | Quinazoline derivatives as vegf inhibitors |
KR100489174B1 (ko) | 1996-03-05 | 2005-09-30 | 제네카-파마 소시에떼아노님 | 4-아닐리노퀴나졸린유도체 |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
DE59801448D1 (de) | 1997-03-27 | 2001-10-18 | Glatt Gmbh | Verfahren zum überwachen und/oder steuern und regeln eines granulations-, agglomerations-, instantisierungs-, coating- und trocknungsprozesses in einer wirbelschicht oder einer bewegten schüttung durch bestimmung der produktfeuchte sowie lufttechnischer apparat zur durchführung des verfahrens |
BR9809451A (pt) * | 1997-05-22 | 2000-06-20 | Searle & Co | Pirazóis substituìdos com 3(5)-heteroarila como inibidores de quinase p38. |
GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
US6200977B1 (en) | 1998-02-17 | 2001-03-13 | Tularik Inc. | Pyrimidine derivatives |
US6247246B1 (en) | 1998-05-27 | 2001-06-19 | Denver Instrument Company | Microwave moisture analyzer: apparatus and method |
ES2274634T3 (es) | 1998-08-29 | 2007-05-16 | Astrazeneca Ab | Compuestos de pirimidina. |
WO2000014552A1 (en) | 1998-09-03 | 2000-03-16 | Malcam Ltd. | Moisture measurement device using microwaves |
US6227041B1 (en) | 1998-09-17 | 2001-05-08 | Cem Corporation | Method and apparatus for measuring volatile content |
NZ511116A (en) | 1998-11-10 | 2003-08-29 | Janssen Pharmaceutica Nv | HIV replication inhibiting pyrimidines |
US6337338B1 (en) | 1998-12-15 | 2002-01-08 | Telik, Inc. | Heteroaryl-aryl ureas as IGF-1 receptor antagonists |
GB9828511D0 (en) | 1998-12-24 | 1999-02-17 | Zeneca Ltd | Chemical compounds |
GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
GB9905075D0 (en) | 1999-03-06 | 1999-04-28 | Zeneca Ltd | Chemical compounds |
DE19917785A1 (de) | 1999-04-20 | 2000-10-26 | Bayer Ag | 2,4-Diamino-pyrimidin-Derivate |
IT1306704B1 (it) | 1999-05-26 | 2001-10-02 | Sirs Societa Italiana Per La R | Anticorpi monoclonali e suoi derivati sintetici o biotecnologici ingrado di agire come molecole antagoniste per il ngf. |
GB9914258D0 (en) | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
US6399780B1 (en) | 1999-08-20 | 2002-06-04 | Cephalon, Inc. | Isomeric fused pyrrolocarbazoles and isoindolones |
DE60023926T2 (de) | 1999-09-10 | 2006-07-20 | Merck & Co., Inc. | Tyrosin kinase inhibitoren |
EA005423B1 (ru) | 1999-09-24 | 2005-02-24 | Янссен Фармацевтика Н.В. | Противовирусные композиции |
US6455525B1 (en) | 1999-11-04 | 2002-09-24 | Cephalon, Inc. | Heterocyclic substituted pyrazolones |
JP4794793B2 (ja) | 1999-12-28 | 2011-10-19 | ファーマコペイア, インコーポレイテッド | N−ヘテロ環TNF−α発現阻害剤 |
CN1429222A (zh) | 2000-02-17 | 2003-07-09 | 安姆根有限公司 | 激酶抑制剂 |
GB0004890D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
GB0004887D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
ES2559273T3 (es) | 2000-05-08 | 2016-02-11 | Janssen Pharmaceutica Nv | Profármacos de pirimidinas que inhiben la replicación del VIH |
CA2406979A1 (en) | 2000-05-31 | 2001-12-06 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
EE200300015A (et) | 2000-07-07 | 2004-10-15 | Angiogene Pharmaceuticals Limited | Kolhinooli derivaadid kui angiogeneesi inhibiitorid |
IL153484A0 (en) | 2000-07-07 | 2003-07-06 | Angiogene Pharm Ltd | Colchinol derivatives as angiogenesis inhibitors |
PL360742A1 (en) | 2000-08-31 | 2004-09-20 | Pfizer Products Inc. | Pyrazole derivatives and their use as protein kinase inhibitors |
EP1317446A1 (en) | 2000-09-01 | 2003-06-11 | Glaxo Group Limited | Oxindole derivatives |
JP2004517049A (ja) | 2000-09-01 | 2004-06-10 | グラクソ グループ リミテッド | チロシンキナーゼ阻害剤としての置換オキシインドール誘導体 |
AU2001292670A1 (en) | 2000-09-15 | 2002-03-26 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
US6613776B2 (en) | 2000-09-15 | 2003-09-02 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
US6660731B2 (en) | 2000-09-15 | 2003-12-09 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
US7473691B2 (en) | 2000-09-15 | 2009-01-06 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
US6610677B2 (en) | 2000-09-15 | 2003-08-26 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
DK1347971T3 (da) | 2000-12-21 | 2006-05-15 | Bristol Myers Squibb Co | Thiazolylinhibitorer af tyrosinkinaser fra Tec-familien |
MXPA03005606A (es) * | 2000-12-21 | 2003-10-06 | Vertex Pharma | Compuestos de pirazol utiles como inhibidores de la proteina cinasa. |
SE0101675D0 (sv) | 2001-05-11 | 2001-05-11 | Astrazeneca Ab | Novel composition |
US6750239B2 (en) | 2001-08-03 | 2004-06-15 | Vertex Pharmaceuticals Incorporated | Pyrazole-derived kinase inhibitors and uses thereof |
EP1423380B1 (en) | 2001-08-03 | 2010-12-15 | Vertex Pharmaceuticals Incorporated | Pyrazole-derived kinase inhibitors and uses thereof |
ATE343575T1 (de) | 2001-09-27 | 2006-11-15 | Smithkline Beecham Corp | Azaoxoindol derivate als trk protein kinase hemmstoffe zur behandlung von krebs und chronischem schmerz |
US6747461B2 (en) | 2001-10-25 | 2004-06-08 | Pioneer Hi-Bred International, Inc. | Apparatus and method for monitoring drying of an agricultural porous medium such as grain or seed |
SE0104140D0 (sv) * | 2001-12-07 | 2001-12-07 | Astrazeneca Ab | Novel Compounds |
JP2003231687A (ja) | 2002-02-04 | 2003-08-19 | Japan Tobacco Inc | ピラゾリル縮合環化合物及びその医薬用途 |
AU2003286711A1 (en) | 2002-10-25 | 2004-05-13 | Vertex Pharmaceuticals Incorporated | Indazolinone compositions useful as kinase inhibitors |
AP2385A (en) * | 2002-12-20 | 2012-03-23 | Pfizer Prod Inc | Pyrimidine derivatives for the treatment of abnormal cell growth. |
MY141220A (en) * | 2003-11-17 | 2010-03-31 | Astrazeneca Ab | Pyrazole derivatives as inhibitors of receptor tyrosine kinases |
PL2332940T3 (pl) | 2004-03-30 | 2013-03-29 | Vertex Pharma | Azaindole użyteczne jako inhibitory JAK i innych kinaz białkowych |
JP2007533717A (ja) | 2004-04-21 | 2007-11-22 | アストラゼネカ アクチボラグ | 化合物 |
US20060106020A1 (en) | 2004-04-28 | 2006-05-18 | Rodgers James D | Tetracyclic inhibitors of Janus kinases |
US7528138B2 (en) | 2004-11-04 | 2009-05-05 | Vertex Pharmaceuticals Incorporated | Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases |
PL1846394T3 (pl) | 2005-02-04 | 2012-04-30 | Astrazeneca Ab | Pochodne pirazoliloaminopirydyny użyteczne jako inhibitory kinazy |
BRPI0608160A2 (pt) | 2005-02-16 | 2010-11-09 | Astrazeneca Ab | anticorpo isolado, célula hospedeira, método de inibir o crescimento de células psma+, e, uso de um anticorpo anti-psma defucosilado |
SI1853588T1 (sl) | 2005-02-16 | 2008-10-31 | Astrazeneca Ab | Kemične spojine |
EP1877057A1 (en) | 2005-04-27 | 2008-01-16 | AstraZeneca AB | Use of pyrazolyl-pyrimidine derivatives in the treatment of pain |
CA2607727A1 (en) | 2005-04-28 | 2006-11-09 | Mitsubishi Tanabe Pharma Corporation | Cyanopyridine derivative and use thereof as medicine |
CN101218229A (zh) | 2005-05-05 | 2008-07-09 | 阿斯利康(瑞典)有限公司 | 吡唑基-氨基取代的嘧啶及其在癌症治疗中的应用 |
EP1899323A2 (en) | 2005-05-16 | 2008-03-19 | AstraZeneca AB | Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors |
BRPI0618011A2 (pt) * | 2005-10-28 | 2011-08-16 | Astrazeneca Ab | composto ou um sal farmaceuticamente aceitável do mesmo, processo para a preparação do mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito anti-proliferativo e um efeito pró-apoptósico em um animal de sangue quente, para tratar doença e para produzir um efeito inibidor de jak em um animal de sangue quente |
SG166827A1 (en) | 2005-11-03 | 2010-12-29 | Vertex Pharma | Aminopyrimidines useful as kinase inhibitors |
UY30444A1 (es) | 2006-06-30 | 2008-01-31 | Astrazeneca Ab | Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos. |
TW200826937A (en) | 2006-11-01 | 2008-07-01 | Astrazeneca Ab | New use |
TW200823196A (en) | 2006-11-01 | 2008-06-01 | Astrazeneca Ab | New use |
-
2006
- 2006-10-26 BR BRPI0618011-6A patent/BRPI0618011A2/pt not_active IP Right Cessation
- 2006-10-26 DK DK06794902.4T patent/DK1945631T3/da active
- 2006-10-26 PT PT06794902T patent/PT1945631E/pt unknown
- 2006-10-26 KR KR1020087011816A patent/KR20080063846A/ko not_active Application Discontinuation
- 2006-10-26 ES ES06794902T patent/ES2391783T3/es active Active
- 2006-10-26 US US12/091,382 patent/US20080287475A1/en not_active Abandoned
- 2006-10-26 JP JP2008537190A patent/JP2009513615A/ja active Pending
- 2006-10-26 WO PCT/GB2006/003978 patent/WO2007049041A1/en active Application Filing
- 2006-10-26 NZ NZ567584A patent/NZ567584A/en not_active IP Right Cessation
- 2006-10-26 AU AU2006307657A patent/AU2006307657B2/en not_active Ceased
- 2006-10-26 EP EP11177767A patent/EP2388259A1/en not_active Withdrawn
- 2006-10-26 RU RU2008120848/04A patent/RU2463302C2/ru not_active IP Right Cessation
- 2006-10-26 PL PL06794902T patent/PL1945631T3/pl unknown
- 2006-10-26 CA CA002626375A patent/CA2626375A1/en not_active Abandoned
- 2006-10-26 TW TW095139565A patent/TW200800963A/zh unknown
- 2006-10-26 EP EP06794902A patent/EP1945631B8/en active Active
- 2006-10-26 MX MX2008005398A patent/MX2008005398A/es not_active Application Discontinuation
- 2006-10-27 AR ARP060104713A patent/AR056210A1/es not_active Application Discontinuation
- 2006-10-27 UY UY29886A patent/UY29886A1/es not_active Application Discontinuation
-
2008
- 2008-04-17 IL IL190935A patent/IL190935A0/en unknown
- 2008-04-22 NO NO20081893A patent/NO20081893L/no not_active Application Discontinuation
- 2008-05-14 EC EC2008008450A patent/ECSP088450A/es unknown
-
2010
- 2010-02-26 US US12/713,695 patent/US8088784B2/en not_active Expired - Fee Related
-
2011
- 2011-12-01 US US13/308,584 patent/US20120071480A1/en not_active Abandoned
-
2012
- 2012-10-15 HR HRP20120824TT patent/HRP20120824T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
ES2391783T3 (es) | 2012-11-29 |
IL190935A0 (en) | 2009-09-22 |
NO20081893L (no) | 2008-05-20 |
BRPI0618011A2 (pt) | 2011-08-16 |
KR20080063846A (ko) | 2008-07-07 |
US8088784B2 (en) | 2012-01-03 |
AU2006307657A1 (en) | 2007-05-03 |
NZ567584A (en) | 2011-08-26 |
US20100160325A1 (en) | 2010-06-24 |
RU2463302C2 (ru) | 2012-10-10 |
EP1945631B8 (en) | 2013-01-02 |
EP2388259A1 (en) | 2011-11-23 |
CA2626375A1 (en) | 2007-05-03 |
TW200800963A (en) | 2008-01-01 |
PT1945631E (pt) | 2012-10-15 |
WO2007049041A8 (en) | 2012-11-01 |
ECSP088450A (es) | 2008-06-30 |
WO2007049041A1 (en) | 2007-05-03 |
AR056210A1 (es) | 2007-09-26 |
PL1945631T3 (pl) | 2012-12-31 |
EP1945631A1 (en) | 2008-07-23 |
EP1945631B1 (en) | 2012-08-08 |
UY29886A1 (es) | 2007-05-31 |
HRP20120824T1 (hr) | 2012-11-30 |
RU2008120848A (ru) | 2009-12-10 |
AU2006307657B2 (en) | 2010-10-28 |
US20080287475A1 (en) | 2008-11-20 |
MX2008005398A (es) | 2008-09-24 |
US20120071480A1 (en) | 2012-03-22 |
JP2009513615A (ja) | 2009-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1945631T3 (da) | 4- (3-aminopyrazole) pyrimidinderivater til anvendelse som tyrosinkinaseinhibitorer til behandling af cancer | |
CY2016045I1 (el) | Παραγωγα νιτροκατεχολης ως αναστολεις της comt | |
DK1761505T3 (da) | Pyrimidin-urinstof-derivater som kinaseinhibitorer | |
DK2261223T3 (da) | Pyrimidinderivater anvendt som PI-3-kinasehæmmere | |
NO20082514L (no) | Aminopyrimidiner anvendelige som kinaseinhibitorer | |
DK1763517T3 (da) | Pyrimidinderivater som 11beta-HSD1-inhibitorer | |
DK1720882T3 (da) | Pyrazolopyrimidin-derivater som cyclin-afhængige kinaseinhibitorer | |
DK1846394T3 (da) | Pyrazolylaminopyridinderivater, der er egnede som kinaseinhibitorer | |
DK1789041T3 (da) | Aryl-pyridinderivater som 11-beta-HSD1-inhibitorer | |
DK2120932T3 (da) | Indazolderivater som kinasehæmmere til behandling af kræft | |
DK1797042T3 (da) | Indozolonderivater som 11B-HSD1-inhibitorer | |
NO20091423L (no) | Pyrimidinderivater og deres anvendelse som kinaseinhibitorer | |
DK1962830T3 (da) | Azaindolhæmmere af aurorakinaser. | |
DK1926722T3 (da) | Substituerede benzimidazoler som kinaseinhibitorer | |
DK1585749T3 (da) | Diazepinoindol-derivater som kinaseinhibitorer | |
DK1841757T3 (da) | Heteroaromatiske quinolin-forbindelser og deres anvendelse som PDE10-hæmmere | |
ATE518860T1 (de) | Pyrroloä2,3-büpyridinderivate als proteinkinaseinhibitoren | |
DK1877232T3 (da) | Fremgangsmåde til behandling af træoverflader | |
DK1928879T3 (da) | Kondenserede heterocykliske forbindelser og anvendelse heraf som kinase-modulatorer | |
CR10369A (es) | Pyrimidine derivatives as pi3k inhibitors | |
DK1979356T3 (da) | Carbonylaminopyrrolopyrazoler, kraftige kinaseinhibitorer | |
DK1740569T3 (da) | Imidazol-derivater som TAFla-inhibitorer | |
DK2021335T3 (da) | Heterocykliske forbindelser som C-FMS-kinasehæmmere | |
DK1711177T3 (da) | 1H-thieno-2,3-c-pyrazolderivater, der er egnede som kinase-I-inhibitorer | |
DK2220070T3 (da) | 2-benzylpyridazinonderivater som Met-kinaseinhibitorer |